Regulatory

What was once an undefined space for dietary supplements has become a regulated, burgeoning market.

Two-thirds of dietary supplement products recalled by FDA remained on the market with adulterated substances, according to JAMA.

A roadmap for navigating the global sourcing landscape

The ingredient can be used at daily doses of up to 1500 mg in sports-friendly formats like nutrition bars and beverages.

A look at opportunity areas and drivers

The American Herbal Products Association says its suggestions to make warning statements less broad-based and more specific to certain populations was well-received.

Four new faces join the USDA's select committee for organic industry recommendations.

The Organic and Natural Health Association will meet the industry’s acquaintance at next week's SupplySide West.

Can an undergarment with the right ingredients help you lose weight? Nope.

Nutritional Outlook interviews CRN's Judy Blatman on just where multivitamins stand these days.

In response to the Bayer Phillips’ Colon Health case, the dietary supplement industry says the agency’s substantiation bar is too high.

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

The bill would enhance DEA's ability to enforce against supplement spikers by expanding the list of controlled substances.

Behind the current omega-3 market decline

Vendors should be held to certain legal requirements-for instance, that farmers selling produce actually grow the produce themselves.

Why it may pay for supplement firms not to settle with patent trolls

But questionable antiaging and diabetes claims are also on the rise.

Chr. Hansen says the process was more complicated because this was the first time the company had filed for a vaginal health claim.

The claim is for Chr. Hansen’s RC-14 and GR-1 Probio-Tech bacterial strains, which target women’s vaginal health.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.